[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pruritus Type Skin Diseases Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

July 2023 | 102 pages | ID: G579D543C05FEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Pruritus Type Skin Diseases Medicine market size was valued at USD 5247.6 million in 2022 and is forecast to a readjusted size of USD 7049.3 million by 2029 with a CAGR of 4.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Pruritus Type Skin Diseases Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Pruritus Type Skin Diseases Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Pruritus Type Skin Diseases Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Pruritus Type Skin Diseases Medicine market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Pruritus Type Skin Diseases Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pruritus Type Skin Diseases Medicine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pruritus Type Skin Diseases Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited and Eli Lilly and Company, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Pruritus Type Skin Diseases Medicine market is split by Type and by Distribution Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • External Medication
  • Oral Medication
Market segment by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Major players covered
  • AbbVie, Inc. (Allergan plc)
  • Albireo Pharma, Inc.
  • Astellas Pharma Inc.
  • Cipla Limited
  • Eli Lilly and Company
  • GSK plc
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc. (Mylan N.V.)
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pruritus Type Skin Diseases Medicine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pruritus Type Skin Diseases Medicine, with price, sales, revenue and global market share of Pruritus Type Skin Diseases Medicine from 2018 to 2023.

Chapter 3, the Pruritus Type Skin Diseases Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pruritus Type Skin Diseases Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and distribution channel, with sales market share and growth rate by type, distribution channel, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pruritus Type Skin Diseases Medicine market forecast, by regions, type and distribution channel, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pruritus Type Skin Diseases Medicine.

Chapter 14 and 15, to describe Pruritus Type Skin Diseases Medicine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Pruritus Type Skin Diseases Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Pruritus Type Skin Diseases Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 External Medication
  1.3.3 Oral Medication
1.4 Market Analysis by Distribution Channel
  1.4.1 Overview: Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel: 2018 Versus 2022 Versus 2029
  1.4.2 Hospital Pharmacies
  1.4.3 Retail Pharmacies
  1.4.4 Online Pharmacies
1.5 Global Pruritus Type Skin Diseases Medicine Market Size & Forecast
  1.5.1 Global Pruritus Type Skin Diseases Medicine Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Pruritus Type Skin Diseases Medicine Sales Quantity (2018-2029)
  1.5.3 Global Pruritus Type Skin Diseases Medicine Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 AbbVie, Inc. (Allergan plc)
  2.1.1 AbbVie, Inc. (Allergan plc) Details
  2.1.2 AbbVie, Inc. (Allergan plc) Major Business
  2.1.3 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Product and Services
  2.1.4 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 AbbVie, Inc. (Allergan plc) Recent Developments/Updates
2.2 Albireo Pharma, Inc.
  2.2.1 Albireo Pharma, Inc. Details
  2.2.2 Albireo Pharma, Inc. Major Business
  2.2.3 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Product and Services
  2.2.4 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Albireo Pharma, Inc. Recent Developments/Updates
2.3 Astellas Pharma Inc.
  2.3.1 Astellas Pharma Inc. Details
  2.3.2 Astellas Pharma Inc. Major Business
  2.3.3 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Product and Services
  2.3.4 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Astellas Pharma Inc. Recent Developments/Updates
2.4 Cipla Limited
  2.4.1 Cipla Limited Details
  2.4.2 Cipla Limited Major Business
  2.4.3 Cipla Limited Pruritus Type Skin Diseases Medicine Product and Services
  2.4.4 Cipla Limited Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Cipla Limited Recent Developments/Updates
2.5 Eli Lilly and Company
  2.5.1 Eli Lilly and Company Details
  2.5.2 Eli Lilly and Company Major Business
  2.5.3 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Product and Services
  2.5.4 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Eli Lilly and Company Recent Developments/Updates
2.6 GSK plc
  2.6.1 GSK plc Details
  2.6.2 GSK plc Major Business
  2.6.3 GSK plc Pruritus Type Skin Diseases Medicine Product and Services
  2.6.4 GSK plc Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 GSK plc Recent Developments/Updates
2.7 Merck & Co., Inc.
  2.7.1 Merck & Co., Inc. Details
  2.7.2 Merck & Co., Inc. Major Business
  2.7.3 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Product and Services
  2.7.4 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Merck & Co., Inc. Recent Developments/Updates
2.8 Pfizer, Inc.
  2.8.1 Pfizer, Inc. Details
  2.8.2 Pfizer, Inc. Major Business
  2.8.3 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Product and Services
  2.8.4 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Pfizer, Inc. Recent Developments/Updates
2.9 Teva Pharmaceutical Industries Ltd.
  2.9.1 Teva Pharmaceutical Industries Ltd. Details
  2.9.2 Teva Pharmaceutical Industries Ltd. Major Business
  2.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Product and Services
  2.9.4 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.10 Viatris Inc. (Mylan N.V.)
  2.10.1 Viatris Inc. (Mylan N.V.) Details
  2.10.2 Viatris Inc. (Mylan N.V.) Major Business
  2.10.3 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Product and Services
  2.10.4 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: PRURITUS TYPE SKIN DISEASES MEDICINE BY MANUFACTURER

3.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pruritus Type Skin Diseases Medicine Revenue by Manufacturer (2018-2023)
3.3 Global Pruritus Type Skin Diseases Medicine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Pruritus Type Skin Diseases Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Pruritus Type Skin Diseases Medicine Manufacturer Market Share in 2022
  3.4.2 Top 6 Pruritus Type Skin Diseases Medicine Manufacturer Market Share in 2022
3.5 Pruritus Type Skin Diseases Medicine Market: Overall Company Footprint Analysis
  3.5.1 Pruritus Type Skin Diseases Medicine Market: Region Footprint
  3.5.2 Pruritus Type Skin Diseases Medicine Market: Company Product Type Footprint
  3.5.3 Pruritus Type Skin Diseases Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Pruritus Type Skin Diseases Medicine Market Size by Region
  4.1.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2018-2029)
  4.1.2 Global Pruritus Type Skin Diseases Medicine Consumption Value by Region (2018-2029)
  4.1.3 Global Pruritus Type Skin Diseases Medicine Average Price by Region (2018-2029)
4.2 North America Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.3 Europe Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.4 Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.5 South America Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.6 Middle East and Africa Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
5.2 Global Pruritus Type Skin Diseases Medicine Consumption Value by Type (2018-2029)
5.3 Global Pruritus Type Skin Diseases Medicine Average Price by Type (2018-2029)

6 MARKET SEGMENT BY DISTRIBUTION CHANNEL

6.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
6.2 Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel (2018-2029)
6.3 Global Pruritus Type Skin Diseases Medicine Average Price by Distribution Channel (2018-2029)

7 NORTH AMERICA

7.1 North America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
7.2 North America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
7.3 North America Pruritus Type Skin Diseases Medicine Market Size by Country
  7.3.1 North America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
  7.3.2 North America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
8.2 Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
8.3 Europe Pruritus Type Skin Diseases Medicine Market Size by Country
  8.3.1 Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
  8.3.2 Europe Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
9.3 Asia-Pacific Pruritus Type Skin Diseases Medicine Market Size by Region
  9.3.1 Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
10.2 South America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
10.3 South America Pruritus Type Skin Diseases Medicine Market Size by Country
  10.3.1 South America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
  10.3.2 South America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
11.3 Middle East & Africa Pruritus Type Skin Diseases Medicine Market Size by Country
  11.3.1 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Pruritus Type Skin Diseases Medicine Market Drivers
12.2 Pruritus Type Skin Diseases Medicine Market Restraints
12.3 Pruritus Type Skin Diseases Medicine Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Pruritus Type Skin Diseases Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pruritus Type Skin Diseases Medicine
13.3 Pruritus Type Skin Diseases Medicine Production Process
13.4 Pruritus Type Skin Diseases Medicine Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Pruritus Type Skin Diseases Medicine Typical Distributors
14.3 Pruritus Type Skin Diseases Medicine Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Pruritus Type Skin Diseases Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel, (USD Million), 2018 & 2022 & 2029
Table 3. AbbVie, Inc. (Allergan plc) Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie, Inc. (Allergan plc) Major Business
Table 5. AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Product and Services
Table 6. AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AbbVie, Inc. (Allergan plc) Recent Developments/Updates
Table 8. Albireo Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Albireo Pharma, Inc. Major Business
Table 10. Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Product and Services
Table 11. Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Albireo Pharma, Inc. Recent Developments/Updates
Table 13. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Astellas Pharma Inc. Major Business
Table 15. Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Product and Services
Table 16. Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Astellas Pharma Inc. Recent Developments/Updates
Table 18. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 19. Cipla Limited Major Business
Table 20. Cipla Limited Pruritus Type Skin Diseases Medicine Product and Services
Table 21. Cipla Limited Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Cipla Limited Recent Developments/Updates
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company Pruritus Type Skin Diseases Medicine Product and Services
Table 26. Eli Lilly and Company Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly and Company Recent Developments/Updates
Table 28. GSK plc Basic Information, Manufacturing Base and Competitors
Table 29. GSK plc Major Business
Table 30. GSK plc Pruritus Type Skin Diseases Medicine Product and Services
Table 31. GSK plc Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GSK plc Recent Developments/Updates
Table 33. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Merck & Co., Inc. Major Business
Table 35. Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Product and Services
Table 36. Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck & Co., Inc. Recent Developments/Updates
Table 38. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer, Inc. Major Business
Table 40. Pfizer, Inc. Pruritus Type Skin Diseases Medicine Product and Services
Table 41. Pfizer, Inc. Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pfizer, Inc. Recent Developments/Updates
Table 43. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceutical Industries Ltd. Major Business
Table 45. Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Product and Services
Table 46. Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 48. Viatris Inc. (Mylan N.V.) Basic Information, Manufacturing Base and Competitors
Table 49. Viatris Inc. (Mylan N.V.) Major Business
Table 50. Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Product and Services
Table 51. Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
Table 53. Global Pruritus Type Skin Diseases Medicine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Pruritus Type Skin Diseases Medicine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Pruritus Type Skin Diseases Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Pruritus Type Skin Diseases Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Pruritus Type Skin Diseases Medicine Production Site of Key Manufacturer
Table 58. Pruritus Type Skin Diseases Medicine Market: Company Product Type Footprint
Table 59. Pruritus Type Skin Diseases Medicine Market: Company Product Application Footprint
Table 60. Pruritus Type Skin Diseases Medicine New Market Entrants and Barriers to Market Entry
Table 61. Pruritus Type Skin Diseases Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Pruritus Type Skin Diseases Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Pruritus Type Skin Diseases Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Pruritus Type Skin Diseases Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Pruritus Type Skin Diseases Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Pruritus Type Skin Diseases Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Pruritus Type Skin Diseases Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Pruritus Type Skin Diseases Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Pruritus Type Skin Diseases Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2023) & (K Units)
Table 75. Global Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2024-2029) & (K Units)
Table 76. Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel (2018-2023) & (USD Million)
Table 77. Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel (2024-2029) & (USD Million)
Table 78. Global Pruritus Type Skin Diseases Medicine Average Price by Distribution Channel (2018-2023) & (US$/Unit)
Table 79. Global Pruritus Type Skin Diseases Medicine Average Price by Distribution Channel (2024-2029) & (US$/Unit)
Table 80. North America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2023) & (K Units)
Table 83. North America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2024-2029) & (K Units)
Table 84. North America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2023) & (K Units)
Table 91. Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2024-2029) & (K Units)
Table 92. Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Pruritus Type Skin Diseases Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2023) & (K Units)
Table 99. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2024-2029) & (K Units)
Table 100. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2023) & (K Units)
Table 107. South America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2024-2029) & (K Units)
Table 108. South America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2023) & (K Units)
Table 115. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2024-2029) & (K Units)
Table 116. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Pruritus Type Skin Diseases Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Pruritus Type Skin Diseases Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Pruritus Type Skin Diseases Medicine Raw Material
Table 121. Key Manufacturers of Pruritus Type Skin Diseases Medicine Raw Materials
Table 122. Pruritus Type Skin Diseases Medicine Typical Distributors
Table 123. Pruritus Type Skin Diseases Medicine Typical Customers

LIST OF FIGURES

Figure 1. Pruritus Type Skin Diseases Medicine Picture
Figure 2. Global Pruritus Type Skin Diseases Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Type in 2022
Figure 4. External Medication Examples
Figure 5. Oral Medication Examples
Figure 6. Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Distribution Channel in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Pruritus Type Skin Diseases Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pruritus Type Skin Diseases Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Pruritus Type Skin Diseases Medicine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Pruritus Type Skin Diseases Medicine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Pruritus Type Skin Diseases Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Pruritus Type Skin Diseases Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Pruritus Type Skin Diseases Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Pruritus Type Skin Diseases Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Distribution Channel (2018-2029)
Figure 31. Global Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Distribution Channel (2018-2029)
Figure 32. Global Pruritus Type Skin Diseases Medicine Average Price by Distribution Channel (2018-2029) & (US$/Unit)
Figure 33. North America Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Distribution Channel (2018-2029)
Figure 35. North America Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Distribution Channel (2018-2029)
Figure 42. Europe Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Distribution Channel (2018-2029)
Figure 51. Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Distribution Channel (2018-2029)
Figure 61. South America Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Distribution Channel (2018-2029)
Figure 67. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Pruritus Type Skin Diseases Medicine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Pruritus Type Skin Diseases Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Pruritus Type Skin Diseases Medicine Market Drivers
Figure 74. Pruritus Type Skin Diseases Medicine Market Restraints
Figure 75. Pruritus Type Skin Diseases Medicine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pruritus Type Skin Diseases Medicine in 2022
Figure 78. Manufacturing Process Analysis of Pruritus Type Skin Diseases Medicine
Figure 79. Pruritus Type Skin Diseases Medicine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications